Post-Severe-COVID-19 Cardiopulmonary Rehabilitation: A Comprehensive Study on Patient Features and Recovery Dynamics

Andreea Dumitrescu1, Gabriela Doros2, Voichita Elena Lazureanu3

  • 1Cardioprevent Foundation, Calea Dorobantilor 3, 300134 Timisoara, Romania.

PubMed

Insights

Severe COVID-19 survivors benefit from tailored cardiopulmonary rehabilitation. Both low- and high-intensity programs significantly improved heart and lung function over three months.

Area of Science:

  • Cardiology
  • Pulmonology
  • Rehabilitation Medicine

Background:

  • Severe COVID-19 often results in significant cardiopulmonary damage, requiring specialized rehabilitation.
  • Post-COVID-19 recovery necessitates interventions to address lingering cardiac and pulmonary impairments.

Purpose of the Study:

  • To evaluate the impact of severe COVID-19 on cardiopulmonary health.
  • To assess the effectiveness of stratified low- and high-intensity rehabilitative interventions in post-COVID-19 patients.

Main Methods:

  • Prospective study of 84 severe COVID-19 patients over 3 months (Sept 2021-Sept 2022).
  • Patients were stratified into individually tailored low- and high-intensity rehabilitation groups.
  • Cardiopulmonary function was monitored, including lung injury, oxygen needs, ejection fraction, and lung volumes.

Main Results:

  • Both rehabilitation groups demonstrated significant improvements in lung injury, oxygen requirements, ejection fraction, and pulmonary artery pressure.
  • Key pulmonary function tests (FVC, FEV1, FEV1/FVC, PEF, FEF 25-75%) showed considerable enhancement.
  • Work intensity and overall cardiopulmonary function improved substantially in both groups over the 3-month period.

Conclusions:

  • Personalized, targeted rehabilitation is effective for improving long-term cardiopulmonary health in severe COVID-19 survivors.
  • Both low- and high-intensity training protocols are sufficient for improving cardiac and lung function within 3 months.
  • Comprehensive cardiopulmonary rehabilitation, stratified by patient recovery, is crucial for post-COVID-19 care.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
355
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
16
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
278
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
12